Physician

Adam Van Nguyen

According to 2025 Medicare claims, Adam Nguyen (NPI: 1568817260) practices dermatology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is ADVANCED DERM-PLASTIC, P.A. (NPI: 1538160304; TIN: 760457947) and primary practice location at 77375-4688.

Nguyen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 630 traditional Medicare patients, billed 2,323 HCPCS/CPT codes, and received $134,579 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 703 prescription claims across 343 beneficiaries totaling $240,347 in drug costs, led by Otezla (Apremilast). Open Payments data shows 31 records totaling $677. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $18,235 to $134,579. Similarly, Part D prescription costs have risen steadily, from $8,610 to $240,347. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$67K$135K2020 Medicare payment: $18,235 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $71,997 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $120,053 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $112,897 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $134,579 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020126354$18,235
20214231,465$71,997
20226742,729$120,053
20237662,797$112,897
20246302,323$134,579

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$192K$383K2016 Drug cost: $8,610 (USD; Tot_Drug_Cst)2017 Drug cost: $48,756 (USD; Tot_Drug_Cst)2018 Drug cost: $18,352 (USD; Tot_Drug_Cst)2019 Drug cost: $53,856 (USD; Tot_Drug_Cst)2020 Drug cost: $22,869 (USD; Tot_Drug_Cst)2021 Drug cost: $12,053 (USD; Tot_Drug_Cst)2022 Drug cost: $84,965 (USD; Tot_Drug_Cst)2023 Drug cost: $383,103 (USD; Tot_Drug_Cst)2024 Drug cost: $240,347 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R55$8,610
201774168$48,756
2018186342$18,352
2019245539$53,856
2020131233$22,869
2021228474$12,053
2022288522$84,965
2023332683$383,103
2024343703$240,347

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more162162$78
11102Biopsy of related skin growth, first growth157176$70
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more352489$63
17000Destruction of precancer skin growth, 1 growth222281$41
17003Destruction of precancer skin growth, 2-14 growths155667$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast26780$116,108
FluocinonideFluocinonide781,764$2,307
MetronidazoleMetronidazole25698$1,770
Clobetasol PropionateClobetasol Propionate26657$1,754
Triamcinolone AcetonideTriamcinolone Acetonide1763,931$1,073

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$677ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Van Nguyen?

Tedicare shows public-source Medicare data for Adam Van Nguyen (NPI 1568817260), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Van Nguyen have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Van Nguyen?

Adam Van Nguyen is linked to ADVANCED DERM-PLASTIC, P.A. (billing NPI 1538160304) in the available physician profile data.

Does Adam Van Nguyen have Open Payments data?

Adam Van Nguyen has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.